mitomycin has been researched along with krn 5500 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, K; Isoe, T; Kamishohara, M; Kataoka, S; Kawai, H; Mochizuki, J; Sakai, T; Tsuruo, T; Uchida, T; Yamaki, H | 1 |
Saijo, N | 1 |
1 review(s) available for mitomycin and krn 5500
Article | Year |
---|---|
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
1 other study(ies) available for mitomycin and krn 5500
Article | Year |
---|---|
Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells.
Topics: Animals; Antineoplastic Agents; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Mice, Nude; Mitomycin; Neoplasms, Experimental; Protein Synthesis Inhibitors; Purine Nucleosides; Subrenal Capsule Assay | 1994 |